Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TenX Keane Acquisition | 1,700,000 | reported | 19 Sept 2025 | tx 6+10,833,333 |
| Citius Pharmaceuticals, Inc. | 89,388 | reported | 08 Aug 2025 | tx 46+47,664,681−8,298,948 |
| Tharimmune, Inc. | 27,353 | reported | 09 Aug 2024 | tx 6+201,086 |
| PHOTOMEDEX INC | 7,534 | reported | 30 Jun 2011 | tx 6+16,284 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Aug 2025 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 125,490 | — | deriv |
| 08 Aug 2025 | OTHER | Citius Pharmaceuticals, Inc. | 89,388 | — | deriv |
| 08 Aug 2025 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 89,388 | — | deriv |
| 08 Aug 2025 | OTHER | Citius Pharmaceuticals, Inc. | 125,490 | — | deriv |
| 19 Sept 2025 | GRANT_AWARD | TenX Keane Acquisition | 1,700,000 | 0.00 USD | |
| 12 Dec 2024 | GRANT_AWARD | TenX Keane Acquisition | 800,000 | 0.00 USD | deriv |
| 07 Nov 2024 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 600,000 | 0.00 USD | deriv |
| 14 Aug 2024 | OTHER | Citius Pharmaceuticals, Inc. | 3,137,255 | — | deriv |
| 14 Aug 2024 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 3,137,255 | — | deriv |
| 25 Sept 2024 | OTHER | Citius Pharmaceuticals, Inc. | 2,234,700 | — | deriv |
| 25 Sept 2024 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 2,234,700 | — | deriv |
| 12 Aug 2024 | GRANT_AWARD | TenX Keane Acquisition | 1,233,333 | 0.00 USD | deriv |
| 09 Aug 2024 | GRANT_AWARD | Tharimmune, Inc. | 2,353 | 0.00 USD | deriv |
| 03 Apr 2024 | OTHER | Citius Pharmaceuticals, Inc. | 1,165,048 | — | deriv |
| 03 Apr 2024 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 1,165,048 | — | deriv |
| 07 Nov 2023 | GRANT_AWARD | Tharimmune, Inc. | 25,000 | 0.00 USD | deriv |
| 10 Oct 2023 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 550,000 | 0.00 USD | deriv |
| 04 Oct 2022 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 550,000 | 0.00 USD | deriv |
| 21 Mar 2022 | GRANT_AWARD | Tharimmune, Inc. | 50,000 | 0.00 USD | deriv |
| 14 Jan 2022 | CONVERSION | Tharimmune, Inc. | 98,733 | 3.20 USD | |
| 14 Jan 2022 | PURCHASE | Tharimmune, Inc. | 25,000 | 4.00 USD | first after silence |
| 14 Jan 2022 | CONVERSION | Tharimmune, Inc. | — | 0.00 USD | deriv |
| 11 Oct 2021 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 650,000 | 0.00 USD | deriv |
| 22 Jul 2021 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 300,000 | 0.00 USD | deriv |
| 06 Oct 2020 | GRANT_AWARD | Citius Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 Jan 2022.